Effects of the probiotic Enterococcus faecalis on symptoms of allergic rhinitis, comparing the probiotic to double-blinded placebo, open-label placebo, and to a no treatment control
Not Applicable
- Conditions
- J30Vasomotor and allergic rhinitis
- Registration Number
- DRKS00015804
- Lead Sponsor
- Medical School Berlin
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 125
Inclusion Criteria
Allergic rhinitis for at least two years. Allergic rhinitis must have been diagnosed by a physician.
Exclusion Criteria
Inability to read and understand the study information; insufficient German language skills;
a medical history of diabetes; gastrointestinal diseases; use of antibiotic medication in the last 6 weeks; pregnancy; perennial allergic rhinitis; chronic rhinosinusitis or any other chronic nasal condition such as anatomical alterations as septum deviation or perforation; any known psychiatric or neurological diseases.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Allergic symptoms and haelth related quality of life before and after the treatment
- Secondary Outcome Measures
Name Time Method Visual-analogue scale to measure the burden of allergic disease and second questionnaire on quality of life before and after the treatment.